Dan Heidari

Dan Heidari is currently the Head of US Atopic Dermatitis Marketing at Eli Lilly and Company, where they are accountable for the US dermatology biologic brand's revenue and operational expenditures. With extensive experience in sales, operations, and brand marketing within the pharmaceutical industry, Dan has successfully led teams and strategies that drove significant performance improvements. Dan also holds a Master of Business Administration from Duke University's Fuqua School of Business and has a proven track record of transforming business challenges into innovative solutions while maintaining integrity and respect for individuals. They are recognized as an authentic leader who is passionate about achieving standout results.